Leukaemias and cancers following iodine-131 administration for thyroid cancer
about
Chronic lymphocytic leukemia radiogenicity: a systematic reviewRadioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastasesChildhood thyroid radioiodine exposure and subsequent infertility in the intermountain fallout cohortNovel approach to analyzing the carcinogenic effect of ionizing radiations.Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma.The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysisSecond primary malignancies in thyroid cancer patients.Radiation-associated urinary bladder cancer.Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy.Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells.Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?Genotoxicity induced by iodine-131 in human cultured lymphocytes.Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes.[Safety of radioiodine therapy in patients with thyroid carcinoma younger than 21 years].Anaplastic transformation from papillary thyroid carcinoma with increased serum CA19-9.Guidelines for the management of thyroid cancer
P2860
Q23921281-3713B45D-E2CA-41D4-9A0D-F1EAFA385E65Q24241189-7A05E291-F6F6-4C75-8D31-20838C57AB89Q28393504-159622AA-E8E8-4195-9CC0-B752F0055953Q30353435-0EB43B63-CA5A-4371-9A0C-2A5350BB0173Q35643680-65EBB367-CA64-423A-9CBC-8A953FE5773CQ35864072-77F5FB88-E262-4603-946B-CE161C3CE373Q35964248-61A4D36E-83ED-4188-B133-33DF486B591EQ36628995-EF47A32E-101D-45DD-BDC1-34C073299D90Q36671533-18115D06-694A-47A4-816F-4BE7BD84BE5CQ37278975-DF217EDE-B457-4B38-8734-5B5E0E8EDB66Q38063414-530008A2-DE75-4A3C-992B-918871988B38Q38125502-3C0FACD2-10EF-4CA0-9FD9-71EEA32EC5C1Q40409652-45923826-7DD8-411D-87A2-B2B9975D8E80Q41148634-59C1EB03-BB82-46B6-9C9E-49A62D55014CQ41534942-06BEA13A-A678-4B6C-848B-22B0F3041503Q42683054-8EACD28F-1C91-4677-8626-32FC2B5A50E4Q44240636-C327D6E3-3343-415A-9BA6-ADA37AB9FD81Q46720797-4FC4359B-3D82-438F-AE1D-67DDDBCA3BBEQ53359748-77AF90BB-1C4D-4021-A319-F8CA09B3847BQ56554243-65D8E7B4-28E9-45FA-8044-9F250ED8C493
P2860
Leukaemias and cancers following iodine-131 administration for thyroid cancer
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@ast
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@en
type
label
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@ast
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@en
prefLabel
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@ast
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@en
P2093
P2860
P356
P1476
Leukaemias and cancers following iodine-131 administration for thyroid cancer
@en
P2093
Challeton C
Delisle MJ
Francese C
Parmentier C
Sancho-Garnier H
Schlumberger M
de Vathaire F
de la Genardiére E
P2860
P2888
P304
P356
10.1038/BJC.1997.130
P407
P577
1997-01-01T00:00:00Z